Awakn Life Sciences

Awakn Life Sciences (NEO: AWKN) is a biotechnology company engaged in clinical operations, research, development, and the provision of psychedelic drugs to improve addiction treatment. Awakn's team consists of world-leading chemists, scientists, psychiatrists, and psychologists who are developing and advancing the next generation of psychedelic drugs, therapies, and technologies for treating addiction. Awakn will also offer evidence-supported psychedelic therapies for addiction in clinics across the UK and Europe, as well as through global licensing partnerships.